Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.37 USD | -4.85% | -16.04% | +83.16% |
Jun. 04 | BMO Capital Raises Price Target on Merus to $91 From $84, Maintains Outperform Rating | MT |
Jun. 04 | Canaccord Genuity Adjusts Price Target on Merus to $67 From $54, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.16% | 3.51B | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Gilead Sciences, Merus Collaborate to Discover New Potential Cancer Therapies